z-logo
open-access-imgOpen Access
Priority of clinical application of photodynamic therapy using the HELBO Thera Lite laser in the treatment of perodonton tissues in parodonton tissues
Author(s) -
T. Matviykiv,
AUTHOR_ID,
М. В. Рожко,
V. Hereliuk,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
sučasna stomatologìâ/sovremennaâ stomatologiâ
Language(s) - English
Resource type - Journals
eISSN - 1992-576X
pISSN - 2786-7641
DOI - 10.33295/1992-576x-2021-4-6
Subject(s) - photodynamic therapy , periodontitis , medicine , intensive care medicine , clinical practice , covid-19 , dentistry , pathology , physical therapy , chemistry , disease , organic chemistry , infectious disease (medical specialty)
. The availability of a huge number of tools, methods and techniques for the treatment of generalized periodontitis is not always effective in clinical practice, especially during a pandemic over COVID-19. The use of high-tech innovative techniques, including photodynamotherapy with HELBO Thera Lite laser can be a particularly promising area as an adjunct to the comprehensive treatment of generalized periodontitis. The technique is characterized by a decent arsenal of advantages over competitors on the market – is 92 % effective against typical periodontal pathogens, minimally invasive, does not require additional use of pharmaceuticals, including antibiotics, does not cause and is not accompanied by excessive psychological stress, has no side effects on others organs and systems. The relevance of its use in dental practice can significantly improve traditional methods of comprehensive treatment of generalized periodontitis, especially in patients after coronavirus infection, which further requires scientifically proved confirmation by studying the features of clinical, microbiological, biochemical and immunological parameters. Key words: generalized periodontitis, photodynamic therapy, Helbo therapy, coronavirus infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here